Patterns of care for brachytherapy in Europe: Updated results
| Autor: | Peter Hoskin, Jean-Jacques Mazeron, Montse Ventura, György Kovács, Didier Peiffert, Richard Pötter, Ferran Guedea, Erik Van Limbergen, Jack L.M. Venselaar, Taran Paulsen Hellebust, Bradley Londres |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Male
medicine.medical_specialty Genital Neoplasms Female medicine.medical_treatment Brachytherapy Descriptive survey Breast Neoplasms Esophagus tumors Cancer Care Facilities Neoplasms Humans Medicine Radiology Nuclear Medicine and imaging Gynecology Response rate (survey) Patterns of care business.industry Obstetrics Guideline adherence Data Collection Prostatic Neoplasms Radiotherapy Dosage Hematology Europe Radiation therapy Oncology Female Guideline Adherence business Prostate brachytherapy |
| Zdroj: | Radiotherapy and Oncology. 97:514-520 |
| ISSN: | 0167-8140 |
| DOI: | 10.1016/j.radonc.2010.09.009 |
| Popis: | Objective: This descriptive survey evaluated brachytherapy (BT) practices and resources in the European area. This was a follow-up study to the original patterns of care for brachytherapy in Europe (PCBE). Materials and methods: A total of 1121 radiotherapy (RT) centres from 41 countries were asked to complete an online questionnaire on BT practices and resources. Countries with fewer than 50% of centres responding were excluded. Participating countries were divided into three groups based on gross domestic product (GDP); group I contained the countries with the highest GDP. Results: The response rate was 56% (633/1121 centres) with 30/41 countries (73%) meeting the inclusion criteria. Sixty percent of reporting centres provided brachytherapy. Responding centres treated an average of 138 (±10, 1 SD) patients with BT; in group I, the mean was 110/centre, an increase of 18% from 2002. CT-dosimetry increased to 61% of centres vs. 33% in 2002. HDR (high-dose rate) BT was the most commonly reported technique (65% of centres). Most BT interventions were for gynaecological tumors (59% of all cases), followed by prostate (17%), breast (9%), lung/bronchus (3%), and esophagus tumors(2%). Conclusion: Gynaecological BT remains the most common application, although both prostate and breast BT have increased. CT-based dosimetry has become increasingly common since 2002. The use of HDR and PDR (pulsed-dose rate) techniques has increased markedly, while both LDR and MDR (medium-dose rate) have declined. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect